insights_auto
Zakaj je tečaj 8NE padel 4,69%?
Podrobneje raziščichevron_right
8NE:FRA
Lisata Therapeutics, Inc.
0,92 €
arrow_downward
−4,69%(−0,045) 1D
8. okt., 08:03:01 GMT +2 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za 8NE …
Odpri
0,92 €
Visoka
0,92 €
Nizka
0,92 €
Tržna kapitalizacija
12,26 mio.
Povprečni promet
0,00
Promet
0,00
52-tedenski najvišji tečaj
4,34 €
52-tedenski najnižji tečaj
0,74 €
Št. zaposlenih
21
Odpri
0,92 €
Visoka
0,92 €
Nizka
0,92 €
Tržna kapitalizacija
12,26 mio.
Povprečni promet
0,00
Promet
0,00
52-tedenski najvišji tečaj
4,34 €
52-tedenski najnižji tečaj
0,74 €
Št. zaposlenih
21
Novice
Iz spletnih virov in novičarskih partnerjev
Yahoo Finance
·
pred 3 urami
Lisata Therapeutics wins new US patent for pancreatic cancer drug
Investing.com
·
pred 3 urami
Lisata Therapeutics receives patent for certepetide cancer treatment
Stock Titan
·
pred 4 urami
A new cancer-treatment patent adds market exclusivity into 2043, Lisata says.
Investing.com UK
·
pred 18 urami
Form PRE 14A Lisata Therapeutics For: 7 October By Investing.com
Profil
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Vizitka: Lisata Therapeutics, Inc.
Generalni direktor-
Št. zaposlenih21
Ustanovljeno1980
SedežBasking Ridge, New Jersey, Združene države Amerike
Sektor-
Spletno mestolisata.com